| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Johnson Craig A is a Director at HERON THERAPEUTICS, INC. /DE/ with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $283K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 21, 2021 | HRTX Heron Therapeutics, Inc. /de/ | Director | Sell | 250 | $9.73 | $2,431.93 | -8.1% | -47.0% | -72.2% | |
| Sep 21, 2021 | HRTX Heron Therapeutics, Inc. /de/ | Director | Sell | 250 | $12.30 | $3,074.10 | -7.5% | -20.3% | -64.7% | |
| Jun 21, 2021 | HRTX Heron Therapeutics, Inc. /de/ | Director | Sell | 250 | $15.20 | $3,800.60 | -7.0% | -21.1% | -81.2% | |
| Apr 6, 2021 | HRTX Heron Therapeutics, Inc. /de/ | Director | Sell | 250 | $17.22 | $4,305.20 | -6.5% | -14.0% | -62.5% |